Effect of oral anticoagulant therapy on fibrinolysis parameters in chronic non-rheumatic atrial fibrillation.
Roldán-Schilling
V
V
Marín-Ortuño
F
F
Marco-Vera
P
P
Sogorb-Garri
F
F
D000074:Acenocoumarol / Q000008:administration & dosage / Q000494:pharmacology; D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use; D000933:Antifibrinolytic Agents; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000187:drug effects; D002908:Chronic Disease; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000187:drug effects; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D; D000074:Acenocoumarol